New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 26, 2012
06:45 EDTAEGRAegerion price target raised to $30 from $25 at Leerink
Leerink raised its price target for Aegerion after the FDA approved Juxtapid. The firm reiterates an Outperform rating on Aegerion, noting the company obtained the broadest possible label possible for Juxtapid.
News For AEGR From The Last 14 Days
Check below for free stories on AEGR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
11:00 EDTAEGROptions with decreasing implied volatility
Subscribe for More Information
July 31, 2014
11:33 EDTAEGROptions with decreasing implied volatility
Subscribe for More Information
July 30, 2014
09:04 EDTAEGROn The Fly: Pre-market Movers
Subscribe for More Information
08:11 EDTAEGRAegerion appoints Craig Fraser as COO
Subscribe for More Information
06:29 EDTAEGRAegerion shares due for 'significant positive bounce,' says Leerink
Subscribe for More Information
July 29, 2014
18:35 EDTAEGROn The Fly: After Hours Movers
Subscribe for More Information
16:49 EDTAEGRAegerion sees 2014 JUXTAPID sales at low end of range
Subscribe for More Information
16:48 EDTAEGRAegerion reports Q2 EPS (6c), consensus (41c)
Reports Q2 revenue $36M, consensus $35.4M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use